The primary market is set for a bumper Rs 80,000-crore bonanza with 30 companies already filing IPO papers to raise Rs 55,000 crore, while around 10 more are lined up for this month itself, seeking to mop up another Rs 25,000 crore, say investment bankers. The market has been on a non-stop rally, hitting new records almost every week, on the back of an influx of investors -- a vast majority of them first-timers -- coupled with a flood of liquidity. Foreign funds alone had pumped in a record $35 billion into the market in FY21, while the trend has continued this fiscal as well. Domestic institutions led by LIC have also infused trillions of rupees, helping woo retail investors in troves -- the year saw over 20 million new investors coming to the market.
A notice issued to the foreign journalists on Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's China National Biotec Group. Sinopharm's COVID-19 vaccine has been granted conditional market approval by China's National Medical Products Administration.
'This government did not have any plan for safety stocks of essential medicines.'
These centres will undertake stem cell clinical research procedures relating to diabetes, cancer, cardiovascular disease, and neurological ischemia.
Monika Halan is editor of Mint Money, India's second-largest business newspaper, which has an exclusive partnership with the Wall Street Journal.
He responded to criticism in certain circles following emergency use authorisation to the vaccine and said,"Indian companies do not deserve this backlash".
Concerned about the rise of antibiotic resistance and the time it takes for drugs developed abroad to reach Indians, the government is considering holding its own clinical trials. Clinical trials for new drugs have so far primarily been conducted only by private Indian or foreign drug firms. But given the stringent nature of India's regulatory environment for clinical trials, several pharmaceutical companies have moved their trials out of India. As a result, only 1.2 per cent of global clinical trials take place in India.
The Duke Clinical Research Institute study found that majority of the paediatric trials enrolled patients in at least one country outside the US.
Gaining a few pounds in college, on a cruise, or over the holidays is considered harmless, but it can have cardiovascular implications, especially if the weight is gained in the abdomen.
Readers share their childhood pictures with us. You can share yours too!
Major drug discovery outsourcing deals have almost dried up in the past 18 months for almost all prominent players in the area
Hospitals and medical research organisations that conduct clinical trials on humans may soon face surprise inspections from the regulatory authorities. The hospitals, the sponsor pharma companies and the institutional ethics committees that oversee these trials will all come under the regulator's scanner.
Hamdard University (Jamia Hamdard) announces its admission notice to the PhD Pharmaceutical Medicine Programme.
The International Center for Training in Clinical Research, (ICTCR) has openings for summer jobs for bright young undergraduates.
At least a dozen global firms, including Roche, Pfizer and Astra Zeneca got a nod from the Drugs Controller General of India to conduct over 50 clinical trials on Indian volunteers this month, official data reveals. The global clinical research outsourcing market is projected to touch $23 billion by 2011, with consultancy firm KPMG estimating that India will corner 15 per cent of this in two years.
The regulator, which is planning to allow first phase of human clinical trials soon, will make registration of clinical research organisations and ongoing clinical trials mandatory.
The new vaccine candidate, DIOS-CoVax2, uses banks of genetic sequences of all known coronaviruses, including those from bats, believed to be the natural hosts of many relatives of human coronaviruses.
It plans to make Hyderabad as its back office hub for data management in clinical research and financial service segments. Novartis is putting infrastructure to put all these people in one place and the centre is expected to turn operational next year. It will be the back office for Novartis' pharmaceutical operations and will find many PhDs and post-graduates working there, said Jurgen Brokatzky-Geiger, head (human resources), Novartis.
'A tornado... when it lands, it swirls through the body, causing chaos, confusion, coughs, wreaking damage to each organ it touches.'
It [becoming a donor] is something that doesn't take much time at all and it is can potentially save lives all over the world. People need to become aware why they need to become donors. South Asians are very giving people and they want to give to the community. This is another way they can help within the community in life and death situations.
'I will take any source of positivity I can get.'
Bilcare Research Academy offers one year, full-time postgraduate diploma in clinical trial management
'If the trial succeeds, it will become the success of Ayurveda.' 'If it's a failure, it's my failure alone.'
India is growing as a preferred destination for global clinical trials and research, with the market being estimated to reach $1.5 billion by 2010, which may trigger a shortage of around 30,000 to 50,000 clinical research professionals by then.
The contract research and manufacturing services may soon replace generic drugs manufacturing as the preferred business option for Indian pharmaceutical industry, if growing revenues from CRAMS business is any indication.
Pharma major GlaxoSmithKline and software giant Tata Consultancy Services on Tuesday signed a 'multi-year, multi-million dollar' contract to set up a global drug development support centre in Mumbai.
Global pharmaceutical major Teva is planning collaborations with Indian partners for clinical research and biotechnology.
Tata Memorial Hospital, Mumbai, invites applications for its Master's Course in Epidemiology and Clinical Research in Oncology.
As many as 150 applications are stuck at evaluation stage, says official.
Her appointment as World Health Organisation's deputy director offers an opportunity to push for improving the medical research environment in India.
India set to become hub for clinical trials
Leading biotech firm, Biocon Ltd, on Tuesday said it would invest $10 million (about Rs 45 crore) in the next 12 months to expand its facilities.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances